Sign in
SYNI Stock Price, Chart, Stats & News
Synvista Therapeutics, Inc.
Save
Synvista Therapeutics, Inc. (SYNI) does not currently pay a dividend.
3
Market cap
–
Current P/E
–
Forward P/E
SYNI chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Pharmaceuticals
Industry
Synvista Therapeutics, Inc. functions as a biopharmaceutical company dedicated to creating both diagnostic tools and therapeutic drugs. Its core objective is to identify and provide treatment options for diabetic patients who are at an elevated risk of developing cardiovascular disease. The company's product portfolio includes ALT-2074, a glutathione peroxidase mimetic currently in Phase II clinical trials, which aims to treat diabetic patients with Hp2-2.
Similar securities
Based on sector and market capitalization
Report issue